About Ipamorelin Dr.

What this site is

Ipamorelin Dr is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on Ipamorelin. We started it for one reason: most of what's online about this peptide is sales copy dressed as information, and the actual studies — the failed trial, the anti-doping detection work, the thin human record — get buried. This site digs them up and cites them.

We are not a clinic. We do not employ clinicians, and we do not provide medical advice. We do not manufacture, sell, or distribute ipamorelin or any other product. Our work is editorial commentary on publicly available science — a reading desk, not a dispensary.

About the name

Yes, the domain says "Dr." No, there is no doctor here, and the name is not a claim that the site offers medical services, consultations, prescriptions, or treatment. The modifier is editorial framing — a posture toward the literature, the way a column might be "the desk" or "the bureau." We don't have doctors, pharmacists, or a clinical team, and we don't pretend to. Anyone implying a peptide site staffed by an actual physician is selling you something is, here at least, correct: we are explicitly none of that.

How we handle the evidence

Three house rules. First, every quantitative claim is cited to a real, verifiable source — PubMed ID or DOI, listed on the references page. Second, we keep anecdote and evidence in separate boxes: community reports are labeled anecdotal and never dressed up as findings. Third, we report doses only as they appear in studies, in third person, and never as a recommendation — no protocols, no "you should." Where the evidence is thin or negative, we say so plainly, because hiding that is exactly the failure this site exists to correct.